BioSpace News Archive

Business

MYOS RENS Technology Reports Fourth Quarter and Fiscal 2018 Results

Conference Call to be Held Thursday, March 28, 2019 , at 11am ET

March 28, 2019
·
16 min read
Job Trends

GB Sciences Study Shows Nevada’s Cannabis Strain Names Have No Correlation to Active Ingredients

What consumers see is not what they get: Study finds almost no chemical diversity in Nevada’s cannabis varieties

March 28, 2019
·
5 min read
Business

BioLineRx Reports Year End 2018 Financial Results and Provides Corporate Update

BL-8040 and AGI-134 oncology programs progressing, with multiple data read-outs expected in the next 12 months

March 28, 2019
·
15 min read
Drug Development

IFM Therapeutics Announces Dosing of First Subjects in Phase 1 Healthy Volunteer Study of Lead NLRP3 Antagonist, IFM-2427

Announcement marks first human trial for an NLRP3 antagonist

March 28, 2019
·
3 min read
Business

Phio and Glycostem to Collaborate on Use of its sd-rxRNA® platform and Glycostem’s oNKord® Cell Therapy Products for the Next Generation of Natural Killer Cell-based Immunotherapy for Cancer Treatment

Phio Pharmaceuticals Corp. announced that it has entered into a research collaboration with Glycostem Therapeutics BV to explore the potential synergies of using Phio’s self-delivering RNAi technology in combination with Glycostem’s proprietary Natural Killer-cell generation technology to develop cellular immunotherapies for cancer treatment with enhanced efficacy and/or safety.

March 28, 2019
·
5 min read
Deals

Can-Fite Reports 2018 Financial Results & Provides Clinical Update

Global distribution deals signed in Europe and China, including Can-Fite’s largest deal to date for up to $74.5 M

March 28, 2019
·
11 min read
Business

Prelude Fertility and Inception Establish the Largest Provider of Comprehensive Fertility Services in the U.S.

New Combined Company Will Dramatically Expand the Quality of Patient Experience and Best-in-Class Care

March 28, 2019
·
4 min read
Biotech Beach

Viking Therapeutics to Participate in Upcoming Investor Conferences - March 28, 2019

Viking Therapeutics, Inc. announced that the company will participate in two upcoming investor conferences.

March 28, 2019
·
2 min read
Business

Khiron VP of Compliance Matt Murphy to Represent Company on U.S. National Cannabis Roundtable With John Boehner, Former Speaker of the U.S. House of Representatives

Matt Murphy, Khiron Vice President of Compliance, and former DEA Chief of Pharmaceutical Investigations recognized for long-time global advocacy and expertise on regulated cannabis markets around the world with appointment to represent Company on National Cannabis Roundtable

March 28, 2019
·
6 min read
Genetown

Best Wellness Employer Awards Announced

Wellness Workdays, a leading provider of corporate wellness programs, announces that 14 organizations achieved 2019 Best Wellness Employer gold certification

March 28, 2019
·
2 min read